DJIA 17,888.35 168.43 0.95%
NASDAQ 5,156.31 47.64 0.93%
S&P 500 2,102.63 22.22 1.07%
market minute promo


161.98 0.88 (0.55%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

AMGN $161.98 0.55%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $162.71
Previous Close $161.10
Daily Range $160.52 - $163.43
52-Week Range $130.09 - $181.81
Market Cap $122.2B
P/E Ratio 19.22
Dividend (Yield) $3.16 (2.0%)
Ex-Dividend Date
Dividend Pay Date
Volume 2,428,914
Average Daily Volume 3,301,129
Current FY EPS $10.08




Drug Makers

Amgen (AMGN) Description

A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology. Website:

News & Commentary

CVS Health Plays Favorites with New Cholesterol Drugs

Amid shifting pharmacy benefit manager policies, Amgen has a chance to dominate the market for next-generation cholesterol drugs.

Benzinga's M&A Chatter for Tuesday December 1, 2015

Repatha Vs. Praluent: Will Amgen's Patents Decide The Race For The Prevailing PCSK9 Inhibitor?

PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for December 02, 2015

25 Stocks For December 2015

What Healthcare Dividend Stock Is Best?

One Motley Fool contributor evaluates three healthcare dividend companies to determine which may be the best investment.

Amgen Inc. Takes Aim at AbbVie Inc.

Amgen has filed an application for approval of its biosimilar to AbbVie's top-selling Humira.

Amgen Seeks FDA Approval for First Biosimilar of Humira

The Zacks Analyst Blog Highlights: BioMarin, Amgen, Vertex, Gilead, Biogen and Repros

These 6 American stocks can handle the stonger dollar and higher rates

See More AMGN News...

AMGN's Top Competitors

AMGN $161.98 (0.55%)
Current stock: AMGN
GILD $105.85 (-0.10%)
Current stock: GILD
CELG $110.56 (1.01%)
Current stock: CELG
$0.00 (0.00%)
Current stock: